A role for bid in eosinophil apoptosis and in allergic airway reaction

Journal of Immunology

Volumn 182, Issue 9, 2009, Pages 5740-5747

  Maret, Marielle ^a   Ruffié, Claude ^a,b   Létuvé, Séverine ^a   Phelep, Aurélie ^a   Thibaudeau, Olivier ^a   Marchal, Joëlle ^a   Pretolani, Marina ^a   Druilhe, Anne ^a,b,c  

^a INSERM   (France)

^b INSTITUT PASTEUR   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS ANTIGEN; FIBRONECTIN; INTERLEUKIN 4; INTERLEUKIN 5; OVALBUMIN; PHOSPHATIDYLSERINE; PROTEIN BCL 2; PROTEIN BID; TRANSFORMING GROWTH FACTOR BETA1; AUTACOID; BID PROTEIN, MOUSE; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BRONCHUS HYPERREACTIVITY; CELL COUNT; CELL CULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA FRAGMENTATION; ENZYME ACTIVITY; EOSINOPHIL; EOSINOPHILIA; LUNG ALVEOLUS CELL; LUNG FLUID; LUNG LAVAGE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SPLEEN CELL; TH2 CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; CYTOLOGY; GENETICS; IMMUNOLOGY; LUNG; MALE; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; RESPIRATORY TRACT ALLERGY;

ANIMALS; APOPTOSIS; BH3 INTERACTING DOMAIN DEATH AGONIST PROTEIN; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; CYTOKINES; EOSINOPHILS; INFLAMMATION MEDIATORS; LUNG; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RESPIRATORY HYPERSENSITIVITY; TH2 CELLS;

EID: 66949179732     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0800864     Document Type: Article

References (60)

1. Djukanovic, R., W. R. Roche, J. W. Wilson, C. R. W. Beasley, O. P. Twentyman, P. H. Howarth, and S. T. Holgate. 1990. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142: 434-457.
2. Bousquet, J., P. Jeffery, W. W. Busse, M. Johnson, and A. M. Vignola. 2000. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am. J. Respir. Crit. Care Med. 161: 1720-1745. (Pubitemid 30329053)
3. Minshall, E. M., D. Y. Leung, R. J. Martin, Y. L. Song, L. Cameron, P. Ernst, and Q. Hamid. 1997. Eosinophil-associated TGF-β1 mRNA expression and airways fibrosis in bronchial asthma. Am. J. Respir. Cell Mol. Biol. 17: 326-333.
4. Lee, J. J., D. Dimina, M. P. Macias, S. I. Ochkur, M. P. McGarry, K. R. O'Neill, C. Protheroe, R. Pero, T. Nguyen, S. A. Cormier, et al. 2004. Defining a link with asthma in mice congenitally deficient in eosinophils. Science 305: 1773-1776.
5. Humbles, A. A., C. M. Lloyd, S. J. McMillan, D. S. Friend, G. Xanthou, E. E. McKenna, S. Ghiran, N. P. Gerard, C. Yu, S. H. Orkin, and C. Gerard. 2004. A critical role for eosinophils in allergic airways remodeling. Science 305: 1776-1779.
6. Trifilieff, A., Y. Fujiatani, A. J. Coyle, M. Kopf, and C. Bertrand. 2001. IL-5 deficiency abolishes aspects of airway remodeling in a murine model of lung inflammation. Clin. Exp. Allergy 31: 934-942. (Pubitemid 34204268)
7. Tanaka, H., M. Komai, K. Nagao, M. Ishizaki, D. Kajiwara, K. Takatsu, G. Delespesse, and H. Nagai. 2004. Role of interleulin-5 and eosinophils in allergen-induced airway remodeling in mice. Am. J. Respir. Cell Mol. Biol. 31: 62-68. (Pubitemid 38888040)
8. Cho, J. Y., M. Miller, K. J. Baek, J. W. Han, J. Nayar, S. Y. Lee, K. McElwain, S. McElwain, S. Friedman, and D. H. Broide. 2004. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest. 113: 551-560.
9. Druilhe, A., B. Wallaert, A. Tsicopoulos, J. R. Lapa e Silva, I. Tillie-Leblond, A. B. Tonnel, and M. Pretolani. 1998. Apoptosis, proliferation and expression of Bcl-2, Fas and Fas ligand in bronchial biopsies from asthmatics. Am. J. Respir. Cell Mol. Biol. 19: 747-757.
10. Vignola, A. M., P. Chanez, G. Chiappara, L. Siena, A. Merendino, C. Reina, R. Gagliardo, M. Profita, J. Bousquet, and G. Bonsignore. 1999. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J. Allergy Clin. Immunol. 103: 563-573.
11. Kodama, T., T. Matsuyama, S. Miyata, H. Nishimura, Y. Nishioka, O. Kitada, and M. Sugita. 1998. Kinetics of apoptosis in the lung of mice with allergic airway inflammation. Clin. Exp. Allergy 28: 1435-1443. (Pubitemid 28559020)
12. Kankaanranta, H., E. Moilanen, and X. Zhang. 2005. Pharmacological regulation of human eosinophil apoptosis. Curr. Drug Targets Inflamm. Allergy 4: 433-445. (Pubitemid 41052408)
13. Tumes, D. J., J. Cormie, M. G. Calvert, K. Stewart, C. Nassenstein, A. Braun, P. S. Foster, and L. A. Dent. 2007. Strain-dependent resistance to allergen-induced lung pathophysiology in mice correlates with rate of apoptosis of lungderived eosinophils. J. Leukocyte Biol. 81: 1362-1373.
14. Simon, H.-U., S. Yousefi, C. Schranz, A. Schapowal, C. Bachert, and K. Blaser. 1997. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J. Immunol. 158: 3902-3908.
15. Tsuyuki, S., C. Bertrand, F. Erard, A. Trifilieff, J. Tsuyuki, M. Wesp, G. P. Anderson, and A. J. Coyle. 1995. Activation of the Fas receptor on lung eosinophils leads to apoptosis and the resolution of eosinophilic inflammation of the airways. J. Clin. Invest. 96: 2924-2931.
16. Chuang, Y.-H., C.-L. Fu, and B.-L. Chiang. 2004. Adenovirus expressing Fas ligand gene decreases airway hyper-responsiveness and eosinophilia in a murine model of asthma. Gene Ther. 11: 1497-1505.
17. Woolley, K. L., P. G. Gibson, K. Carty, A. J. Wilson, S. H. Twaddell, and M. J. Woolley. 1996. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am. J. Respir. Crit. Care Med. 154: 237-243. (Pubitemid 26255795)
18. Ikeda, K., J. Nayar, J. Y. Cho, M. Miller, M. Rodriguez, E. Raz, and D. H. Broide. 2003. Resolution of airway inflammation following ovalbumin inhalation: comparison of ISS DNA and corticosteroids. Am. J. Respir. Cell Mol. Biol. 28: 655-663.
19. Duez, C., A. Tomkinson, L. D. Shultz, D. L. Bratton, and E. W. Gelfand. 2001. Fas deficiency delays the resolution of airway hyperresponsiveness after allergen sensitization and challenge. J. Allergy Clin. Immunol. 108: 547-556. (Pubitemid 32978025)
20. Tong, J., H. S. Bandulawa, B. S. Clay, R. A. Anders, R. A. Shilling, D. D. Balachandran, B. Chen, J. V. Weinstock, J. Solway, K. J. Hamann, and A. I. Sperling. 2006. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J. Exp. Med. 203: 1173-1184. (Pubitemid 43736588)
21. Druilhe, A., S. Létuvé, and M. Pretolani. 2003. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8: 481-495. (Pubitemid 37247991)
22. Druilhe, A., Z. Cai, S. Hailé, S. Chouaib, and M. Pretolani. 1996. Fas-mediated apoptosis in cultured human eosinophils. Blood 87: 2822-2830. (Pubitemid 26102232)
23. Barnhart, B. C., E. C. Alappat, and M. E. Peter. 2003. The CD95 type I/type II model. Semin. Immunol. 15: 185-193.
24. Létuvé, S., A. Druilhe, M. Grandsaigne, M. Aubier, and M. Pretolani. 2001. Involvement of caspases and of mitochondria in Fas ligation-induced eosinophil apoptosis: modulation by interleukin-5 and interferon-γ. J. Leukocyte Biol. 70: 767-775. (Pubitemid 33127011)
25. Segal, M., S. Niazi, M. P. Simons, S. A. Galati, and J. G. Zangrilli. 2007. Bid activation during induction of extrinsic and intrinsic apoptosis in eosinophils. Immunol. Cell Biol. 85: 518-524. (Pubitemid 47530584)
26. Yin, X.-M., K. Wang, A. Gross, Y. Zhao, S. Zinkel, B. Klocke, K. A. Roth, and S. J. Korsmeyer. 1999. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 400: 886-891.
27. Proust, B., C. Ruffié, J. Lefort, and B. B. Vargaftig. 2002. Bronchopulmonary hyperreactivity and lung eosinophil sequestration but not their migration to the alveolar compartment are independent of interleukin-5 in allergic mice. Eur. Cytokine Network 13: 340-349. (Pubitemid 35015072)
28. Lagranderie, M., M.-A. Nahori, A.-M. Balazuc, H. Kiefer-Biasizzo, J.-R. Lapa e Silva, G. Milon, G. Marchal, and B. B. Vargaftig. 2003. Dendritic cells recruited to the lung shortly after intranasal delivery of Mycobacterium bovis BCG drive the primary immune response towards a type 1 cytokine production. Immunology 108: 352-364.
29. Shida, K., R. Takahashi, E. Iwasate, K. Takamizawa, H. Yasui, T. Sato, S. Habu, S. Hachimura, and S. Kaminogawa. 2002. Lactobacillus casei strain Shirota suppresses immunoglobulin E and immunoglobulin G1 responses and systemic anaphylaxis in a food allergy model. Clin. Exp. Allergy 32: 563-570. (Pubitemid 34429576)
30. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65: 55-63. (Pubitemid 14203433)
31. Hansen, G., V. P. Yeung, G. Berry, D. T. Umetsu, and R. H. DeKruyff. 2000. Vaccination with heat-killed Listeria as adjuvant reverses established allergeninduced airway hyperreactivity and inflammation: role of CD8+ T cells and IL-18. J. Immunol. 164: 223-230. (Pubitemid 30012994)
32. Trifilieff, A., A. El-Hasim, R. Corteling, and C. E. Owen. 2000. Abrogation of lung inflammation in sensitized Stat6-deficient mice is dependent on the allergen inhalation procedure. Br. J. Pharmacol. 130: 1581-1588. (Pubitemid 30611935)
33. Lapa e Silva, J. R., C. M. Bachelet, M. Pretolani, D. Baker, R. J. Scheper, and B. B. Vargaftig. 1993. Immunopathologic alterations in the bronchi of immunized guinea pigs. Am. J. Respir. Cell Mol. Biol. 9: 44-53.
34. Van Oosterhout, A. J. M., D. Fattah, I. Van Ark, G. Hofman, T. L. Buckley, and F. P. Nijkamp. 1995. Eosinophil infiltration precedes development of airway hyperreactivity and mucosal exudation after intranasal administration of interleukin-5 to mice. J. Allergy Clin. Immunol. 96: 104-112.
35. Trifilieff, A., A. El-Hasim, and C. Bertrand. 2000. Time course of inflammatory and remodeling events in a murine model of asthma: effect of steroid treatment. Am. J. Physiol. 279: L1120-L1128. (Pubitemid 32009498)
36. Underwood, D. C., R. R. Osborn, C. J. Kotzer, J. L. Adams, J. C. Lee, E. F. Webb, D. C. Carpenter, S. Bochnowicz, H. C. Thomas, D. W. P. Hay, and D. E. Griswold. 2000. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration and persistence. J. Pharmacol. Exp. Ther. 293: 281-288.
37. Altemeier, W. A., X. Zhu, W. R. Berrington, and J. M. Harlan. 2007. Fas (CD95) induces macrophage proinflammatory chemokine production via a Myd88-dependent, caspase-independent pathway. J. Leukocyte Biol. 82: 721-728.
38. Park, D. R., A. R. Thomsen, C. W. Frevert, U. Pham, S. J. Skerrett, P. A. Kiener, and W. C. Liles. 2003. Fas (CD95) induces proinflammatory cytokine responses by human monocytes and monocyte-derived macrophages. J. Immunol. 170: 6209-6216.
39. Uller, L., K. Rydell-Törmänen, C. G. A. Persson, and J. S. Erjefält. 2005. Anti-Fas mAb-induced apoptosis and cytolysis of airway tissue eosinophils aggravates rather than resolves established inflammation. Respir. Res. 6: 90. (Pubitemid 41410147)
40. Sexton, D. W., M. G. Blaylock, and G. M. Walsh. 2001. Human alveolar epithelial cells engulf apoptotic eosinophils by means of integrin- and phosphatidylserine receptor-dependent mechanisms. A process upregulated by dexamethasone. J. Allergy Clin. Immunol. 108: 962-969.
41. Verhoven, B., S. Krahling, R. A. Schlegel, and P. Williamson. 1999. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ. 6: 262-270. (Pubitemid 29145830)
42. Odaka, C., and T. Mizuochi. 2002. Macrophages are involved in DNA degradation of apoptotic cells in murine thymus after administration of hydrocortisone. Cell Death Differ. 9: 104-112. (Pubitemid 34144770)
43. Kurusaka, K., M. Takahashi, N. Watanabe, and Y. Kobayashi. 2003. Silent cleanup of very early apoptotic cells by macrophages. J. Immunol. 171: 4672-4679.
44. Mangahas, P. M., and Z. Zhou. 2005. Clearance of apoptotic cells in Caenorhabditis elegans. Semin. Cell Dev. Biol. 16: 295-306.
45. Sexton, D. W., and G. W. Walsh. 2005. Airway inflammation resolution. Clin. Exp. Allergy 35: 838-840.
46. Uller, L., C. G. A. Persson, and J. S. Erjefält. 2006. Resolution of airway disease: removal of inflammatory cells through apoptosis, egression or both? Trends Pharmacol. Sci. 27: 461-466. (Pubitemid 44251226)
47. Takeda, K., A. Haczku, J. J. Lee, C. G. Irvin, and E. W. Gelfand. 2001. Strain dependence of airway hyperresponsiveness reflects differences in eosinophil localization in the lung. Am. J. Physiol. 281: L394-L402. (Pubitemid 32756051)
48. Gochuico, B. R., K. M. Miranda, E. M. Hessel, J. J. de Bie, A. J. Van Oosterhout, W. W. Cruikshank, and A. Fine. 1998. Airway epithelial Fas ligand expression: potential role in modulating bronchial inflammation. Am. J. Physiol. 274: L444-L449. (Pubitemid 28158264)
49. Komai, M., H. Tanaka, T. Masuda, K. Nagao, M. Ishizaki, M. Sawada, and H. Nagai. 2003. Role of Th2 responses in the development of allergen-induced airway remodeling in a murine model of allergic asthma. Br. J. Pharmacol. 138: 912-920. (Pubitemid 36390648)
50. Leigh, R., R. Ellis, J. Wattie, D. S. Southam, M. de Hoogh, J. Gauldie, P. O'Byrne, and M. D. Inman. 2002. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am. J. Respir. Cell Mol. Biol. 27: 526-535. (Pubitemid 35301806)
51. Kang, H.-R., S. J. Cho, C. G. Lee, R. J. Homer, and J. A. Elias. 2007. Transforming growth factor (TGF)-β1 stimulates pulmonary fibrosis and inflammation via a Bax-dependent, Bid-activated pathway that involves matrix metalloproteinase-12. J. Biol. Chem. 282: 7723-7732.
52. Zhang, Y., W. J. Lamm, R. K. Albert, E. Y. Chi, W. R. Henderson, Jr., and D. B. Lewis. 1997. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am. J. Respir. Crit. Care Med. 155: 661-669. (Pubitemid 27085817)
53. + T cells generate intermediate caspase activity and cleavage of caspase-8 substrates. J. Immunol. 174: 3999-4009.
54. Rautajoki, K. J., E. M. Marttila, T. A. Nyman, and R. Lahesmaa. 2007. Interleukin-4 inhibits caspase-3 by regulating several proteins in the Fas pathway during initial stages of human T helper 2 cell differentiation. Mol. Cell. Proteomics 6: 238-251.
55. Elkon, K. B. 1999. Caspases: multifunctional proteases. J. Exp. Med. 190: 1725-1727.
56. Siegel, R. M. 2006. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 6: 308-317.
57. Budd, R. C., W.-C. Yeh, and J. Tschopp. 2006. cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6: 196-204.
58. Anel, A., A. Bosque, J. Naval, A. Pineiro, L. Larrad, M. A. Alava, and M. J. Martinez-Lorenzo. 2007. Apo2L/TRAIL and immune regulation. Front Biosci. 12: 2074-2084.
59. Iwata, A., K. Nishio, R. K. Winn, E. Y. Chi, W. R. Henderson, Jr., and J. M. Harlan. 2003. A broad-spectrum caspase inhibitor attenuates allergic airway inflammation in murine asthma model. J. Immunol. 170: 3386-3391. (Pubitemid 36302218)
60. Karlen, S., M. L. de Boer, R. J. Lipscombe, W. Lutz, V. A. Mordvinov, and C. J. Sanderson. 1998. Biological and molecular characteristics of interleukin-5 and its receptor. Int. Rev. Immunol. 16: 227-247. (Pubitemid 28102255)